Property of a Lady Boucheron, nephrite/jade and diamond cigarette case (Boucheron, Porta sigarette in nefrite/giada e diamanti) Lot Closed October 19, 12:21 PM GMT Estimate 6,000 - 10,000 EUR Lot Details Description Boucheron, nephrite/jade and diamond cigarette case (Boucheron, Porta sigarette in nefrite/giada e diamanti) 1905 The rectangular nephrite/jade case set, enhanced with rose diamonds, one diamond deficient, measurements 90 x 55 x 13mm approximately, French assay mark for platinum and maker's mark for Boucheron, unsigned, case stamped Boucheron
The FDAs proposal to ban menthol cigarettes and flavored cigars will have a profound and certain impact in reducing these health disparities
The math is sobering
PDF page 19 of the Guide tells doctors and other health care providers that: "Pharmacotherapy is recommended for all dependent smokers who express an interest in quitting, except where contraindicated." Doctors are told that "first line options are medicines that have been shown to be effective" and in "Australia these are NRT (brands include Chemist's Own Nicotine, Nicabate CQ, Nicorette, Nicotinell, QuitX and others), varenicline (brand name Champix) and sustained release preparations of bupropion hydrochloride (brand names Buproprion-RL, Clorprax, Prexaton and Zyban SR)." PDF page 29 tells physicians that "all forms of NRT (at equivalent doses) are similarly effective in aiding long term cessation," that "all forms of NRT can increase the rate of quitting by 50-70 percent." Not once does the Guide warn doctors that NRT's 50-70% rate reflects efficacy over placebo, findings from studies that we now know were not blind as claimed
